𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Search for loss of heterozygosity and mutation analysis of KRIT1 gene in CCM patients

✍ Scribed by Valeria Marini; Loretta Ferrera; Francesca Pigatto; Paola Origone; Cecilia Garrè; Alessandra Dorcaratto; Giuseppe Viale; Francesco Alberti; Cristina Mareni

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
53 KB
Volume
130A
Category
Article
ISSN
1552-4825

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BRCA1 gene mutation and loss of heterozy
BRCA1 gene mutation and loss of heterozygosity on chromosome 17q21 in primary prostate cancer
✍ Toyoaki Uchida; Chunxi Wang; Takefumi Sato; Jiangping Gao; Rikiya Takashima; Aki 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 113 KB 👁 1 views

The tumor suppressor gene BRCA1 on chromosome 17q21 has been characterized and shown to be mutated in patients with familial breast and ovarian cancer. Several studies examined the relatives of women with breast cancer and noted an association with ovarian and prostate cancer. This study investigate

Linkage analysis and loss of heterozygos
Linkage analysis and loss of heterozygosity for chromosome arm 1p in familial breast cancer
✍ Robert C. Millikan; Sue A. Ingles; Anh T. Diep; Shanyan Xue; Nianmin Zhou; Barba 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 2 views

We conducted linkage analysis of 64 multiple-case families with early-onset bilateral breast cancer using DNA markers on chromosome band 1p36. Evidence against tight linkage was obtained using a dominant model for transmission (summary LOD scores at recombination fraction ϭ 0.000001 were -4.71 for D

Loss of heterozygosity on chromosome 9 a
Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers
✍ Françoise Muzeau; Jean François Fléjou; Gilles Thomas; Richard Hamelin 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 131 KB 👁 1 views

Loss of heterozygosity on chromosome 9 has been reported in a variety of human cancers. The cyclin-dependent kinase inhibitor p16 gene, mapped on chromosome 9p21, is presumed to be the tumor-suppressor gene localized in this chromosome. The aim of our study was to determine, in 26 Barrett's adenocar

K-ras mutation and loss of heterozygosit
K-ras mutation and loss of heterozygosity of the adenomatous polyposis coli gene in patients with colorectal adenomas with in situ carcinoma
✍ N. Peter Zauber; Marlene Sabbath-Solitare; Stephen P. Marotta; D. Timothy Bishop 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

## BACKGROUND. The majority of colorectal carcinomas, if not all, arise from a benign adenoma. The DNA of the carcinomatous cells frequently has mutations in several genes. However, it is not exactly clear when during the neoplastic process each mutation develops. An adenoma with an area of in sit

Mutation analysis and loss of heterozygo
Mutation analysis and loss of heterozygosity of PEDF in central nervous system primitive neuroectodermal tumors
✍ Irene Slavc; Ignacio R. Rodriguez; Krzysztof Mazuruk; Gerald J. Chader; Jaclyn A 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 120 KB 👁 2 views

Deletion of 17p is the most frequent abnormality observed in central nervous system (CNS) primitive neuroectodermal tumors (PNETs), implicating the presence of a tumor suppressor gene which maps to 17p. The gene for pigment epitheliumderived factor (PEDF) has been cloned and mapped to 17p13. PEDF be